ORTHO VISION MAX ID-MTS
Report
- Report Number
- 2250051-2020-00033
- Event Type
- Malfunction
- Date Received
- July 17, 2020
- Date of Event
- June 30, 2020
- Report Date
- July 16, 2020
- Manufacturer
- ORTHO CLINICAL DIAGNOSTICS
- Product Code
- KSZ
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- OTHER
Narratives
DISCORDANT POSITIVE WEAK D(RH1) ANTIGEN RESULT FOR ONE PATIENT. THE MOST PROBABLE ROOT-CAUSE IS ANALYZER-RELATED, DUE TO THE CARRY-OVER OF A HIGH TITER ANTI-B ANTIBODY INTO THE WEAK D TEST. NO BIASED RESULT WAS REPORTED TO A PHYSICIAN. THE PATIENT WAS NOT HARMED.
A CUSTOMER COMPLAINED AFTER OBTAINING WHAT WAS DESCRIBED AS A DISCORDANT WEAK D(RH1) ANTIGEN TYPING RESULT FOR ONE PATIENT USING THE ORTHO BIOVUE SYSTEM IN CONJUNCTION WITH THEIR ORTHO VISION MAX BIOVUE ANALYZER. COMPLAINANT/COMPLAINT REPORTER: (B)(6) ¿ LABORATORY TECHNICIAN. EVENT DATE: (B)(6) 2020. REPORTED ON: (B)(6) TO ORTHOCARE HELPDESK. REAGENTS: ORTHO SERA ANTI-D(IAT) LOT V216330 EXPIRY DATE 21 FEBRUARY 2022. ORTHO BIOVUE SYSTEM AHG ANTI-IGG CASSETTE LOT IGC075F EXPIRY DATE 17 OCTOBER 2020. ORTHO BIOVUE SYSTEM ADK CASSETTE LOT ADK044J EXPIRY DATE 17 OCTOBER 2020 . SOFTWARE VERSION: 5.12.8. PATIENT INFORMATION: MALE; AGED 73; PLANNED FOR SURGERY. IT IS UNDERSTOOD THAT ON 30 JUNE 2020, THE CUSTOMER HAD TESTED A PATIENT¿S SAMPLE FOR ABO/D TYPING USING ORTHO BIOVUE SYSTEM ADK CASSETTE LOT ADK044J IN CONJUNCTION WITH THEIR ORTHO VISION MAX BIOVUE ANALYZER AND THAT THEY HAD OBTAINED: A B BLOOD GROUP. NEGATIVE REACTIONS WITH THE 2 ANTI-D(RH1) REAGENTS FROM THE CASSETTE. THE CUSTOMER REPORTED THAT ON THE SAME DAY, THEY HAD TESTED THE SAME SAMPLE FOR WEAK D(RH1) TYPING USING ORTHO SERA ANTI-D(IAT) LOT V216330 AND ORTHO BIOVUE SYSTEM AHG ANTI-IGG CASSETTE LOT IGC075F IN CONJUNCTION WITH THEIR ORTHO VISION MAX BIOVUE ANALYZER AND THAT THEY HAD OBTAINED A POSITIVE REACTION (3+ REACTION STRENGTH). THE CUSTOMER REPORTED THAT THEY TESTED THE SAME SAMPLE FOR WEAK D(RH1) TYPING USING AN ALTERNATIVE COMMERCIALLY AVAILABLE METHOD (GRIFOLS COMBI ANTI-D MONOTYPE LOT 650519011A IN TUBE METHOD) AND THAT THEY HAD OBTAINED A NEGATIVE REACTION. THE CUSTOMER REPORTED THAT ON (B)(6) 2020, THEY HAD RE-TESTED THE SAME SAMPLE FOR WEAK D(RH1) TYPING IN CONJUNCTION WITH THEIR ORTHO VISION MAX BIOVUE ANALYZER AND THAT THEY HAD OBTAINED THE EXPECTED NEGATIVE REACTION. NO FURTHER DETAIL WAS PROVIDED. THE CUSTOMER REPORTED THAT NO BIASED RESULT HAD BEEN REPORTED TO A PHYSICIAN. THE CUSTOMER REPORTED THAT THE PATIENT HAD NOT BEEN HARMED AS A RESULT OF THE REPORTED EVENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 751505 | ORTHO VISION MAX ID-MTS | AUTOMATED BLOOD GROUPING & ANTIBODY TEST SYSTEM | KSZ | ORTHO CLINICAL DIAGNOSTICS | 5.12.8 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |